News
iCAD gets FDA nod for colon cancer detection product
August 5, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | CommentsNashua, N.H.-based image and analysis solutions company iCAD Inc. has announced that the U.S. Food and Drug Administration has approved the company's VeraLook computer-aided detection product used to analyze virtual colonoscopy exams.
Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010
August 5, 2010 10:36 am | by Bio-Medicine.Org | CommentsNEWTON, Mass. , Aug. 5 /- Microfluidics International Corporation (OTC Bulletin Board: MFLU ) announced today the Company will release second quarter 2010 financial results on Tuesday, August 10, 2010 , at 8:30am ET . (Logo: http://photos.prnewswire.com/prnh/20090811/NE59652LOGO )...
JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
August 5, 2010 8:35 am | by Bio-Medicine.Org | CommentsCLEVELAND , Aug. 5 /- JumpStart Ventures , which invests in and partners with innovative, early-stage companies in Northeast Ohio , announced an investment commitment of $250,000 in drug development company ChanRx. The two-year-old company is developing a pharmaceutical compound to treat...
Cornerstone Therapeutics Announces Development of Generic for Tussionex®
August 5, 2010 8:34 am | by Bio-Medicine.Org | CommentsCARY, N.C. , Aug. 5 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its...
Diagnostics firm Ikonisys lands $3.8M
August 5, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | CommentsIkonisys Inc., a New Haven, Conn.-based diagnostics device firm, has raised $3.8 million of a planned $12 million equity and warrants offering, according to a regulatory filing. The company develops a platform that serves as the basis of diagnostic products for identifying cancer and birth defects.
Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
August 5, 2010 8:33 am | by Bio-Medicine.Org | CommentsIRVINE, California , and AMSTERDAM , August 5, 2010 /- Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington...
Omnicare 2Q net income falls, shares drop
August 5, 2010 7:45 am | by The Associated Press | CommentsOmnicare Inc. said Thursday its net income fell 60 percent in the second quarter on lower pharmacy services revenue.The company, which dispenses drugs to nursing homes and long-term care facilities, also cut its outlook for the year, helping to send its shares down 11 percent in morning trading...
Making Spider-Strength Materials
August 5, 2010 5:37 am | by Massachusetts Institute of Technology | CommentsGenetically modified bacteria can produce enough proteins for super-strong spider silk.
ImmunoGen sees sharp revenue drop for fiscal 2010
August 5, 2010 5:37 am | by Mass High Tech: The Journal of New England Technology | CommentsWaltham biotech ImmunoGen Inc. ended its fiscal 2010 with less than half of the revenue it reported for fiscal 2009, mainly due to a drop in license and milestone fee revenue.
Draft Guidance for Industry and Food and Drug Administration Staff - Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays
August 5, 2010 5:36 am | by U.S. Food & Drug Administration | CommentsThese assays are intended to quantitatively measure concentrations of the respective drugs in serum or plasma as an aid in the management of patients treated with lamotrigine or zonisamide. The recommendations are based on current review practices as...
In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Ne...
August 5, 2010 5:36 am | by Bio-Medicine.Org | CommentsWALTHAM, Mass. , Aug. 5 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection (CDI), nearly 70 percent of surveyed infectious disease...
Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
August 5, 2010 5:36 am | by Bio-Medicine.Org | CommentsBEIJING , Aug. 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading developer and provider of vaccines in China , announced today that it will release its financial results for the second quarter ended June 30, 2010 before the open of the market on Monday, August 16, 2010...
Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter
August 5, 2010 5:33 am | by Bio-Medicine.Org | CommentsCHICAGO , Aug. 5 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the...
Sharp Community Medical Group Taps IBM and ActiveHealth Collaborative Care Solution to Help Doctors Deliver Better Patient Care
August 5, 2010 4:37 am | by IBM | CommentsSAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Sharp Community Medical Group (SCMG) announced today it will employ a new Collaborative Care Solution unveiled today by IBM (NYSE: IBM) and ActiveHealth Management to connect the medical group's 200 primary care physicians and 500 specialists...
ActiveHealth and IBM Pioneer Cloud Computing Approach to Help Doctors Deliver High Quality, Cost Effective Patient Care
August 5, 2010 4:36 am | by IBM | CommentsIBM (NYSE: IBM) and ActiveHealth Management, an Aetna (NYSE: AET) subsidiary, today unveiled a new cloud computing and clinical decision support solution that will enable medical practices, hospitals and states to change the way they deliver healthcare, providing better quality care at a...
